Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.605NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.36.29ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.36.29ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.36.29ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.36.29NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.596ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.596ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.596ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.596NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
W.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
W.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
W.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
W.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.565ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.565ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.565ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.565NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.361ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.361ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.361ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.361NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.101ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.101ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-16984.7China
B.1.1.101ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.101NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.478ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.478ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.478ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.478NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.177.86ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.177.86ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.177.86ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.86NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.543ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.543ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.543ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.543NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.139ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.139ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.139ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.139NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
C.31ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
C.31ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
C.31ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
C.31NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.221ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.221ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.221ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.221NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.362ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used